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Abstract
Our previous studies have shown that nutritional zinc restriction exacerbates airway inflammation accompanied by an
increase in caspase-3 activation and an accumulation of apoptotic epithelial cells in the bronchioles of the mice. Normally,
apoptotic cells are rapidly cleared by macrophage efferocytosis, limiting any secondary necrosis and inflammation. We
therefore hypothesized that zinc deficiency is not only pro-apoptotic but also impairs macrophage efferocytosis. Impaired
efferocytic clearance of apoptotic epithelial cells by alveolar macrophages occurs in chronic obstructive pulmonary disease
(COPD), cigarette-smoking and other lung inflammatory diseases. We now show that zinc is a factor in impaired
macrophage efferocytosis in COPD. Concentrations of zinc were significantly reduced in the supernatant of bronchoalveolar
lavage fluid of patients with COPD who were current smokers, compared to healthy controls, smokers or COPD patients not
actively smoking. Lavage zinc was positively correlated with AM efferocytosis and there was decreased efferocytosis in
macrophages depleted of Zn in vitro by treatment with the membrane-permeable zinc chelator TPEN. Organ and cell Zn
homeostasis are mediated by two families of membrane ZIP and ZnT proteins. Macrophages of mice null for ZIP1 had
significantly lower intracellular zinc and efferocytosis capability, suggesting ZIP1 may play an important role. We
investigated further using the human THP-1 derived macrophage cell line, with and without zinc chelation by TPEN to
mimic zinc deficiency. There was no change in ZIP1 mRNA levels by TPEN but a significant 3-fold increase in expression of
another influx transporter ZIP2, consistent with a role for ZIP2 in maintaining macrophage Zn levels. Both ZIP1 and ZIP2
proteins were localized to the plasma membrane and cytoplasm in normal human lung alveolar macrophages. We propose
that zinc homeostasis in macrophages involves the coordinated action of ZIP1 and ZIP2 transporters responding differently
to zinc deficiency signals and that these play important roles in macrophage efferocytosis.
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Introduction
The phagocytic activity of macrophages is important not only
for immune response to micro-organisms but also for removal of
apoptotic cells in tissues in a process known as efferocytosis (Latin,
efferre, ‘‘to carry to the grave’’) [1]. Impairment of efferocytosis
can lead to accumulation of apoptotic cells and their secondary
necrosis, releasing factors that promote an inflammatory response.
Efferocytosis is impaired by a number of agents including cigarette
smoke and is an important pathogenic mechanism in chronic
inflammatory diseases of the lung such as chronic obstructive
pulmonary disease (COPD) [2–7]. There is interest, therefore, in
factors which regulate efferocytosis.
One such factor is zinc (Zn), the second most abundant metal in
the body and important for many physiological and pathological
processes, especially in the immune system. Increased prevalence
of obstructive lung disorders [8] and lung (but not breast or
prostate) cancer [9] are associated with low dietary Zn intake and
thought to be due, at least in part, to protective effects of Zn
against cadmium, a metal ion with similar chemistry to Zn but
which is toxic and accumulates in AM of smokers [10]. Amongst
the actions of Zn ions on the immune system are its effects on
phagocytic cells including monocytes, macrophages and dendritic
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cells [11–13]. Phagocytosis is impaired in Zn deficient mice and
restored by Zn supplements [14,15]. Studies from Guidot and
colleagues [16,17] have suggested links between lung injury,
impaired phagocytosis and Zn deficiency. In rats, stresses to the
lung caused by alcohol [17] or virus [16,18] resulted in significant
decreases in GM-CSF receptor expression and phagocytosis of
bacteria by AM. These were accompanied by a significant decline
in lung Zn concentrations, as measured by Zn in BAL fluid
supernatant and AM. A causative role for Zn deficiency in
macrophage impairment is supported by decrease in AM
phagocytosis of bacteria by chelation of intracellular Zn in vitro
induced by the membrane-permeable Zn chelator N,N,N’,N’-
tetrakis-(2-pyridyl-methyl) ethylenediamine (TPEN). In addition,
alcohol-fed rats had a 5-fold decrease in capacity to clear
inoculated Klebsiella pneumonia from their lungs and this, as well
as increased oxidative stress in the lung, could be prevented by
dietary zinc supplementation [19]. These findings were extended
to human chronic alcoholic subjects who had significantly
decreased AM Zn levels, bacterial phagocytosis and expression
of GM-CSF receptor; treating AM with Zn in vitro improved their
phagocytic function [20]. Collectively, these studies showed that
Zn is required to maintain AM bacterial phagocytosis, and that
pulmonary Zn deficiency could be one of the mechanisms by
which chronic HIV-1 infection and alcohol abuse impair AM
immune function and predispose to pneumonia and other lung
infections.
Little is known about Zn in macrophage efferocytosis of
apoptotic cells and its effects in chronic lung diseases including
COPD. It is also not known how macrophages regulate their levels
of Zn including their responses to Zn deficiency. Critical to the
normal cellular and tissue homeostasis of Zn is the role of specific
membrane Zn transporter proteins. Based on their sequence
homology and structural properties, Zn transporters have been
assigned to two families: SLC39A (also known as ZIPs) and
SLC30A (also known as ZnTs) [21]. ZIPs usually have 8 trans-
membrane domains and either mediate uptake of Zn across the
plasma membrane (e.g. ZIP4) or regulate release of Zn into the
cytosol from organelles such as the endoplasmic reticulum and
Golgi (e.g. ZIP7). They are particularly important in restoring
normal cytosolic levels of Zn in Zn-deprived cells. ZnTs generally
have 6 trans-membrane domains and have opposing actions,
lowering cytosolic Zn by facilitating efflux from cells (e.g. ZnT1) or
uptake of the metal ions from cytosol into intracellular organelles
(e.g. ZnT4). A range of Zn transporters are expressed in the lung
[22], including special roles for three influx membrane ZIP
transporters. ZIP1 is lost, along with Zn, in the lungs of rats with
acute lung injury [17]. ZIP8 is increased at mRNA and protein
levels in the lungs of chronic smokers and may play a pivotal role
in the ensuing damage since, on the one hand, it transports Zn
which protects airway epithelium and is anti-inflammatory in the
lungs [23,24] while it also transports cadmium (Cd) a toxic metal
in inhaled cigarette smoke that accumulates in the lungs [25].
ZIP14 is a major influx transporter for Zn in pulmonary
endothelium [26].
If efferocytosis is Zn-dependent, this might explain our earlier
observations of a marked accumulation of apoptotic epithelial cells
in the lungs of mice with combined airway inflammation and
nutritional Zn deprivation as well as reduced efferocytosis in the
airway and lungs of patients with COPD and smoke exposed mice
[2,4,5,27]. What is required now is a systematic characterization of
Zn homeostasis in macrophages and a study of its role in
efferocytosis. We firstly assessed Zn levels in BAL of human
COPD subjects and healthy subjects, with and without a recent
history of smoking, and correlated with AM efferocytosis activity.
Next we assessed the effects of Zn depletion on efferocytosis in
AM. To investigate the effect of Zn depletion on gene expression
of ZIP transporters, we used human THP-1 macrophages [28].
Confirmation of protein expression and subcellular localization of
ZIP transporter proteins was determined by immunofluorescence
in THP-1 cells and normal human lung sections. Further
investigation of the role in efferocytosis of one of these transporters
ZIP1 was carried out using ZIP1 null mice [29].
Materials and Methods
Subject populations and collection of samples
Human ethics approval was granted by the institutional review
board for human studies at the Royal Adelaide Hospital (RAH),
which approved the protocols; all procedures were undertaken
after written fully informed consent from the subjects. BAL was
collected from controls (normal lung function and no history of
lung disease, cancer or allergy) and COPD subjects who were
further sub-classified according to smoking history [2–4,6]. AM
were purified by adhesion to plastic as we have reported [4].
Primary lung tissue was obtained from a separate group of patients
undergoing curative-intent lobectomy as previously reported
[30,31]. All COPD subjects had moderate severity disease (GOLD
stage 2) and there were no significant associations between disease
severity and Zn levels among these subjects.
Materials
Zn sulphate (cell culture grade), ovalbumin, TPEN, PMA and
DAPI and ß-mercaptoethanol were from Sigma-Aldrich (Sydney,
NSW, Australia). Other reagents were obtained as described below
or in the text.
Zn measurement in human bronchoalveolar fluid (BAL)
BAL were centrifuged and supernatants frozen at –80uC until
assayed for Zn. BAL Zn was assayed by a Zinquin-based
fluorometric technique [32] as follows. Briefly, 100 mL of BAL
samples (or stock Zn sulphate solutions) were added in triplicates to
wells of 96-well black plates (BD Biosciences, North Ryde, NSW,
Australia). To these were added 100 mL of Zinquin Assay buffer
(Chelex treated, Zn-free 1X Hank’s balanced salt solution with
0.3 mg/ml ovalbumin and 10 mM Zinquin ester. After 40 min
incubation at room temp in the dark, fluorescence was read using
excitation filter (355 nm) and emission filter (510–10 nm) in a
FLUOstar Optima fluorescence plate reader (BMG Labtech,
Mornington, Victoria, Australia) and converted to Zn concentra-
tion from a standard curve.
THP-1 cell culture
A differentiated THP-1 human monocytic cell line (ATCC,
Rockville, MD) was applied as these cells behave very much like
native monocyte-derived macrophages and have been used
extensively to study mechanisms involved in human macrophage
differentiation [28]. Cells were cultured in RPMI 1640 media
supplemented with 2 mM GlutaMaxTM 10% fetal calf serum
(FCS) and 1% Penicillin:Streptomycin (all from Life Technologies,
Carlsbad, CA) and 0.05 mM ß-mercaptoethanol. THP-1 cells
(16106) were differentiated into macrophages in 6-well plates in
2 mL of RPMI 1640 medium containing 0.1 mM of PMA over
48 hr at 37uC. Differentiation was assessed by adherence to
plastic. and determination of plasma membrane CD11B expres-
sion using flow cytometry as described [33]. To deplete
intracellular Zn, aliquots of cells were treated for 4 h with
16 mM of TPEN. Since TPEN is a known apoptotic inducer of
cells [34], a loss in cell viability in TPEN-treated cells could
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potentially confuse interpretation of some of the findings. The
effect of TPEN treatment on apoptosis of THP-1 macrophages
was assessed using flow cytometry and 7AAD staining. The
percentage apoptosis of cells both pre-and post- treatment was less
than 1%. Therefore, under the conditions (concentration and
exposure time) used in this study, there was no effect of TPEN on
apoptosis.
Flow cytometric measurement of labile Zn using FluoZin-
3
AM, THP-1 cells or PMA treated THP-1 cells (scraped from
culture dish) were loaded with FluoZin-3 AM ester (1 mM, Life
Technologies) in culture medium at 37uC for 30 min, washed with
1 mL of FACS buffer (1X PBS, 0.5% BSA, 2 mM EDTA) and
resuspended in 100 mL of FACS buffer. Cells were loaded with
FluoZin-3 and incubated with anti-CD11b conjugated with
phycoerythrin (PE) for 30 min on ice in the dark. Fluorescence
was recorded using a FACS Canto II (BD). Cells were gated
relative to an unstained control and the percentage of cells that
stained positive was determined. The following controls were used
to determine compensation between FITC and PE channels:
unstained cells to determine appropriate FSC and SSC PMT
settings, and cells loaded with FluoZin-3 AM ester alone and cells
stained with CD11b PE alone to determine compensation between
both channels. BAL Zn levels were not considered an issue as
macrophages were washed twice before the assay and cells further
washed with FACS buffer before staining with CD11b PE.
qRT-PCR
Cells were immediately placed in RLT lysis buffer (Qiagen,
Chadstone Centre, Victoria, Australia). Total RNA was isolated as
per kit instructions (RNeasy mini kit, Qiagen). cDNA was
prepared from 2 mg of total RNA using a high capacity cDNA
reverse transcription kit (Applied Biosystems, Mulgrave, Victoria,
Australia). Quantitative PCR was performed using 33 ng of cDNA
as template in 10 mL reactions using pre-made TaqMan primer/
probes (Applied Biosystems) with TaqMan gene expression master
mix and run on an Applied Biosystems ViiA7 Real Time PCR
system. Hypoxanthine guanine phosphoribosyl transferase
(HPRT) and 18S rRNA were used as endogenous controls. Data
was analysed by the delta-delta Ct method, and expressed as fold
change (with 95% confidence intervals).
Immunofluorescence antibodies, reagents and
fluorescence microscopy
Immunofluorescence of Zn transporters in THP-1 cells or
formalin-fixed lung biopsies was performed as described for
inflammasome proteins [35]. Human ZIP1 polyclonal antibody
was raised in sheep [36]. Primary antibodies, other than ZIP1,
were from commercial sources including rabbit polyclonal
antibodies to human ZIP2 (Abcam74707, Sapphire Bioscience,
Waterloo, NSW; Australia). In some experiments, sections were
co-stained for CD68 (PG-M1, Dako Australia Pty. Ltd, Nth
Sydney, NSW, Australia) or DAPI (200 ng/mL). F(ab’)2 fragment
secondary antibodies were from Jackson ImmunoResearch (Aba-
cus ALS, Brisbane, QLD, Australia). Cytospins were fixed with
2.5% formalin and permeabilized with 0.1% SDS. Images were
captured on a Zeiss Apoptome microscope (Carl Zeiss GmbH,
Goettingen, Germany).
Efferocytosis assay
Efferocytosis of apoptotic epithelial cells by macrophages was
performed as we have previously described using apoptotic human
or mouse lung epithelial cells at a ratio of 1:10 macrophages:a-
poptotic cells as phagocytic targets [5,6]. The efferocytic index was
determined as the percentage of macrophages ingesting apoptotic
cells.
Animal Studies
The Animal Care and Ethics Committees of the IMVS and the
University of Adelaide approved animal procedures (Permits M-
37-08 and M-67-09) and procedures conformed to ARRIVE
guidelines, NIH guidelines (Guide for the Care and Use of
Laboratory Animals. NIH publication No. 86–23) and to National
Health and Medical Research Guidelines to promote the well-
being of animals used for scientific purposes: The assessment and
alleviation of pain and distress in research animals (2008). In our
experiments, all efforts were made to minimize suffering of the
mice. Prior to obtaining peritoneal macrophages, mice were
anaesthetized with isofluorane and humanely killed by cervical
dislocation. ZIP12/2 mice were provided by Jim Geiser and Glen
Andrews (Univ of Kansas Medical Center, Kansas) [29] and back-
crossed to a C57BL/6s background. Matings of heterozygotes
provided the ZIP12/2 null mice and ZIP1+/+ wild-type controls.
Mice were maintained in the the Institute of Medical and
Veterinary Science (IMVS, Gilles Plains, Australia) animal care
SPF facility (22uC with a 12 h light-dark cycle). Access to water
and a non-purified diet (Milling Industries, Adelaide, Australia)
were provided ad libitum.
Isolation of Mouse Peritoneal Macrophages and
Phagocytosis Assay
For good yield of macrophages we obtained peritoneal
macrophages. Female mice (average size 22 g), randomly selected
from null or wild-type controls, were injected ip with 1 mL of 4%
Brewer’s Thioglycollate broth (Sigma-Aldrich, Nth Ryde, NSW).
After 2 days, mice were sacrificed (see above) prior to obtaining
peritoneal macrophages. Cells were centrifuged at 800 RPM and
seeded (36105 cells) into wells of 24-well plates in RPMI+
GlutaMaxTM with 10% foetal bovine serum and 1% Penicillin:-
Streptomycin. Plates were incubated for 2 hrs to allow macro-
phages to adhere to the plate. Non-adherent cells were removed
and adherent macrophages resuspended in RPMI+GlutamaxTM
medium. Phagocytosis of apoptotic murine epithelial cells by
mouse peritoneal macrophages was performed as previously
described [5,6].
Statistical analysis
Data was analysed using SPSS software and Mann-Whitney or
1-way ANOVA with post hoc for nonparametric analyses.
Correlations were performed using Spearman’s rank test. Analyses
were performed using SPSS software. P values,0.05 were
considered significant.
Results
1. Zn concentrations in human BAL
Zn levels were determined in BAL from 20 controls, 17 healthy
smokers, 20 current and 19 ex-smoker COPD subjects. Mean BAL
Zn concentration was significantly decreased in COPD patients
who were current smokers, compared to controls p,0.05 (Mann
Whitney, Fig. 1A). Mean BAL Zn concentrations were lower in
healthy smokers and ex-smoker COPD subjects compared to
controls, but p values did not reach significance. There was no
significant correlation between age and BAL Zn concentration
amongst those with COPD (Pearson Correlation, p =20.125).
A Role for Zinc and Zinc Transporters in Efferocytosis
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2. Zn and AM efferocytosis
Correlations were performed on a cohort of 38 subjects for
which both efferocytosis and Zn data were available (Fig. 1B).
Further correlations were performed on a cohort of 17 subjects for
which both efferocytosis and intracellular labile Zn levels in
patients’ AM were available (Fig. 1C). The groups contained
normal, smoker, COPD smoker and COPD ex-smokers at similar
proportions to those in Figure 1A. A significant correlation
between BAL Zn levels and % efferocytosis of apoptotic human
16HBE bronchial epithelial cells was found (n = 38, correlation
coefficient 0.345, p = 0.025, Spearman’s rho) (Fig. 1B). There was
strong correlation between intracellular labile Zn levels in patients’
AM (measured by FluoZin-3 fluorescence) and % efferocytosis
(correlation coefficient 0.722, p = 0.001, Fig. 1C).
3. Changes in Zn transporter expression during TPEN-
induced Zn depletion of THP-1 cells
To mimic Zn deficiency, THP-1 monocytes or macrophages
were treated for 4 h with the membrane permeable Zn chelator
TPEN. The effects of TPEN on mRNA expression for the Zn
transporters and other Zn-related proteins are shown in Fig. 2 as
mean values with 95% confidence intervals.
a) ZIP family of Zn transporters. ZIP2 mRNA signifi-
cantly increased in TPEN-treated THP-1 monocytes (28.3-fold,
p,0.001) and THP-1 macrophages (2.9-fold (p,0.005). TPEN
significantly decreased mRNA levels of ZIP4 in both monocytes
(0.4-fold, p,0.001) and macrophages (0.5-fold, p,0.05). There
were similar decreases in ZIP7 but these only reached significance
in macrophages (0.5-fold, p,0.05); in monocytes, p value was
0.065. ZIP11 was significantly decreased in monocytes (0.6-fold,
p,0.05) but not in macrophages. There were no effects of Zn
depletion by TPEN on expression of the other nine ZIP
transporters (ZIP1,3,5,6,8,9,10,13,14). ZIP12 was not expressed
in either cell type.
b) ZnT family of Zn transporters. TPEN significantly
decreased mRNA expression of ZnT1 (0.2-fold, p,0.001) and
ZnT6 (0.4-fold, p,0.002) in both monocytes and macrophages.
ZnT5 mRNA was also significantly decreased by TPEN
treatment, 0.6-fold (p,0.001) and 0.3-fold (p,0.05), respectively,
in the two cell types. ZnT3 was significantly decreased by TPEN in
macrophages (0.3-fold, p,0.001) but not in monocytes while
ZnT7 was significantly decreased in monocytes (0.3-fold, p,
0.001) but not in macrophages. TPEN treatment had no
significant effect on ZnT2,4, 8, 9 or 10 mRNA levels (Fig. 2).
4. Immunofluorescence localization of ZIP1 and ZIP2 on
human macrophages
Two sources of human macrophages were studied, PMA-
induced THP1 macrophages and in situ alveolar macrophages
from lung sections from non-tumour areas of biopsies obtained
from patients undergoing lung tumour resection surgery. Alveolar
macrophages were identified by labelling with a mouse monoclo-
nal antibody to CD68.
ZIP1. ZIP1 was labelled with a sheep polyclonal antibody. It
was strongly expressed in macrophages and localized, predomi-
nantly, to the plasma membrane and cytoplasm of both THP1
Figure 1. Relationship between efferocytosis and BAL and macrophage Zn content. A: Zn levels in BAL from COPD and smokers. Zn levels
were determined in BAL from 20 controls, 17 healthy smokers, 20 current and 19 ex-smoker COPD subjects. Box plots present median 625th and
75th percentiles (solid box) with the 10th and 90th percentiles shown by whiskers outside the box. Asterix indicates significantly (p,0.05) lower
expression vs. controls. B: Correlation between BAL Zn levels and % efferocytosis. A significant correlation between BAL Zn levels and % efferocytosis
of apoptotic bronchial epithelial cells was also found (correlation coefficient 0.345, p = 0.025, Spearman’s rho). C: Correlation between intracellular Zn
levels and % efferocytosis. Figure shows a strong positive correlation between intracellular labile Zn levels (measured by FluoZin-3 fluorescence) and
% efferocytosis in patients’ AM.
doi:10.1371/journal.pone.0110056.g001
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macrophages (Fig. 3A) and alveolar macrophages (Fig. 3B),
consistent with a role as a Zn influx transporter. Negative controls
in which the primary antibody was replaced by normal sheep IgG
showed no binding of conjugate (Fig. 3C).
ZIP2. ZIP2 was weakly expressed on THP1 macrophages and
mainly on the nucleoli (Fig. 3D). Localization in the nucleolus was
confirmed by Z-section analysis (not shown). On the other hand,
there was strong expression of surface and cytoplasmic ZIP2 on
alveolar macrophages. This was a consistent finding with several
patients’ lung sections, two of which are shown in panels E and F.
5. Effect of ZIP1 KO on cytosolic Zn levels and
efferocytosis in mouse peritoneal macrophages
These experiments used a ZIP1 null mouse strain. For good
yield of macrophages we obtained peritoneal macrophages after ip
injection of adjuvant 2 days previously.
Cytosolic Zn. Fig. 4A shows that cytosolic Zn (as measured
by flow cytometry using the Zn fluorophore FluoZin-3) was
significantly (p,0.05) decreased from 25.8% Zn +ve cells (SEM
5.9, n= 25 mice) in the macrophages of ZIP1+/+ mice to 7.6% +ve
cells (SEM 1.6, n= 14 mice) in macrophages of ZIP12/2 mice.
Fluorescence was inhibited by pre-treatment of macrophages for
4 h with 16 mM Zn chelator TPEN (not shown), confirming the
Zn dependence of the assay.
Efferocytosis. Next we assayed efferocytosis of apoptotic
epithelial cells by the peritoneal macrophages as per our published
method for AM [5,6]. With ZIP1+/+ macrophages, the efferocytic
index was 20.9% (SEM 0.8, data pooled from 2 experiments,
n = 14 mice, Fig. 4B). This was significantly (p,0.005) decreased
in the ZIP12/2mice to 12.2% (SEM 0.8, data pooled from 2
experiments, n = 12 mice). When the isolated macrophages were
depleted of Zn by treatment with 16 mM TPEN for 4 h, the
efferocytic index was decreased by 25% in the macrophages from
the ZIP1+/+ mice but there was no further decrease in efferocytosis
in the macrophages from the ZIP12/2 mice (not shown).
Discussion
Recent studies have highlighted the importance of maintaining
sufficient lung Zn levels [16,17,27,37,38]. In the first section of this
manuscript, we report significantly decreased BAL Zn in COPD
patients who were current smokers, compared to healthy
volunteers, smokers and COPD patients without recent smoking
history. It is not clear whether the low lung Zn levels in the
actively-smoking COPD patients are a manifestation of a systemic
Zn deficiency or whether they indicate a Zn deficiency that is
restricted to the lungs. Plasma Zn has been shown to be an
unreliable indicator of systemic Zn levels since it is subject to
change during the acute phase response in response to inflamma-
tion, infection or trauma [39]. In this regard other studies have
shown no change, a significant decrease or a significant increase in
plasma Zn concentrations in COPD patients compared to healthy
controls [40–42].
Having shown a Zn deficiency in BAL from COPD patients, we
then focussed on the potential role of the zinc deficiency in the
Figure 2. Zn transporter mRNA expression in THP-1 monocytes and macrophages in response to intracellular Zn depletion. THP-1
monocytes and PMA differentiated THP-1 macrophages were treated with 16 mM TPEN for 4 h. RNA was isolated and target genes were detected
using Taqman probes, with HPRT-1 and 18S RNA used as endogenous controls for 3 separate experiments (n = 3). Data is presented as mean fold
change (695% CI) compared to control (untreated) cells. * p: ,0.05, ** p: ,0.01, *** p: ,0.001.
doi:10.1371/journal.pone.0110056.g002
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defective AM efferocytosis ability that we have previously reported
in COPD. Both BAL Zn and AM Zn were positively correlated
with the capacity of AM to efferocytose apoptotic bronchial
epithelial cells. The link between macrophage efferocytosis ability
and Zn was further shown in a murine model: when isolated
macrophages were depleted of Zn by treatment with TPEN, the
macrophage efferocytic index was decreased by 25%. Importantly
this effect was abolished by knocking out of ZIP1, furthermore
confirming that Zn was essentially involved. The exact mecha-
nisms by which Zn deficiency impairs efferocytosis are unclear, but
current data suggest they are complex. Thus, a pathway of CD44-
mediated activation of CR3 which is implicated in phagocytosis
and efferocytosis has been shown to be dependent on divalent
cations including Zn but not Ca [43]. A further mechanism may
involve an impaired differentiation of monocytes to macrophages
in Zn deficiency, e.g. due to defective expression of a receptor for
GM-CSF [18]. In support of the latter, we have previously shown
an increase in undifferentiated macrophages in the lungs of COPD
patients who are current smokers compared to never smokers and
COPD subjects who had ceased smoking [2]. These smoking
related changes may contribute to reducing the overall rate of
efferocytosis in the lung, as undifferentiated macrophages have
reduced phagocytic ability. It is possible that sustained low BAL
Zn levels, as a direct consequence of exposure to cigarette smoke,
may lead to a resultant loss of AM Zn by replacement of Zn with
Cd in AM [25], although this requires further investigation.
What causes the low lung Zn levels in smokers with COPD is
not precisely known although it is possible that cigarette smoke-
induced inflammation and lung injury plays a role. In animal
models of airway inflammation or acute lung injury, there were
abnormalities in airway epithelial or AM Zn transporter expres-
sion, including ZIP1, without systemic Zn deficiency [17,44]. Lung
injury and inflammation may therefore lead to a down-regulation
in lung Zn transporter expression that lowers Zn concentrations in
the lung fluids, airways and AM and results in impaired clearance
of dying airway and alveolar epithelial cells.
A gap in the literature is the paucity of information on Zn
homeostasis in the macrophage and the mechanisms by which Zn
influences critical functions of the macrophage such as efferocy-
tosis. We have therefore begun to characterize those Zn
transporters important for monocyte/macrophage Zn homeosta-
sis. Cellular Zn homeostasis involves, in part, the coordinate action
Figure 3. Immunolocalization of ZIP1 and ZIP2 transporters in humanmacrophages. A: Plasma membrane-like localization of ZIP1 (red) in
PMA-differentiated THP-1 macrophages. B–C: Staining of human lung sections (non-tumour area) for ZIP1 (red, B) and negative control (C). D: Sparse
and predominantly nucleolar localization of ZIP2 in PMA-differentiated THP-1 macrophages. E–F: Staining of human lung sections (non-tumour area)
for ZIP2. Macrophages were identified in separate experiments using CD68 marker (not shown). Panels E and F are representative microphotos of
ZIP2 staining (red) of macrophages in two different patient biopsies, showing surface and cytoplasmic fluorescence. Blue =DAPI staining of nuclei.
Scale bar represents 50 mm for all microphotos, and 16.7 mm in the insets.
doi:10.1371/journal.pone.0110056.g003
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of two families of Zn transporters with opposing actions. ZIP
transporters increase cytosolic Zn by importing extracellular Zn or
by releasing organelle stores of Zn into the cytosol. ZnT
transporters export Zn or compartmentalize it into organelles. In
particular, there is a need to identify the plasma membrane Zn
importers responsible for bringing Zn into the monocytes and
macrophages.
One strategy is to look for up-regulation of Zn transporters in
response to induced Zn deficiency. Of interest, when the THP-1
monocytes or macrophages were rendered Zn-deficient in vitro,
by exposing to the membrane-permeable Zn chelator TPEN,
there was no change in ZIP1 expression indicating that this Zn
transporter is unlikely to be involved in maintaining cytosolic Zn
levels during Zn deficiency. However, mRNA for ZIP-2 gene
increased significantly 28-fold and 3-fold, respectively. This
suggests that ZIP-2 is an important Zn transporter for these cells
under Zn-deprived conditions. It is interesting that the increase
was almost 10-fold greater for monocytes than macrophages. This
may indicate that macrophages have more substantial reserves of
zinc. Of the three ZIP transporters that decreased at the mRNA
level with Zn depletion, ZIP4 is a plasma membrane Zn importer
while ZIP5 and ZIP7 are transporters involved in efflux of Zn into
the cytosol from ER, Golgi and other organelles. ZIP5 and ZIP7
proteins may, therefore, have a role in maintaining cytosolic Zn
levels during Zn deficiency.
None of the ZnT type Zn transporters increased in gene
expression in Zn-depleted monocytes or macrophages, while many
decreased in expression. Notably, there were large decreases in
ZnT1, a transporter that is primarily involved in efflux of Zn out of
the cell. Decrease in ZnT1 expression is likely involved in
maintaining intracellular Zn when extracellular Zn is limited.
There were also decreases in ZnT5-7. Since these are involved in
sequestration of Zn into organelles, their decrease might also help
to conserve cytosolic Zn.
Joshi and colleagues have previously identified ZIP1 as being
important for lung Zn homeostasis and AM phagocytosis of
bacteria [17]. We confirmed the presence of ZIP1 protein at the
surface, and in the cytoplasm, of THP-1 macrophages and human
AM (the latter by immunofluorescence co-localization of ZIP1 and
CD68 on macrophages in paraffin-embedded sections of normal
lung tissue from patients undergoing lobectomy). Our immuno-
fluorescence studies also showed ZIP2 on the surface and in the
cytoplasm of alveolar macrophages. Interestingly, there was only
weak, nucleolar-like staining for ZIP2 in THP1 macrophages.
Nucleoli are known to be rich in Zn [45]. While presence of ZIP2
in nucleoli requires confirmation by other techniques such as cell
fractionation, we believe this is the first report of a candidate
nucleolar Zn transporter. The function of nucleolar Zn is unclear
but Zn is important for RNA polymerase [46]. Since ZIP1 gene
expression is up-regulated in Zn-deprived THP1 cells, the
decreased level of ZIP2 protein in THP1 macrophages, as
opposed to in situ alveolar macrophages, may be a reflection of
higher concentrations of Zn ions in the THP1 culture medium
compared to in vivo lung fluids. The latter is difficult to measure
since the process of obtaining lung fluid lavages introduces a
dilution factor.
In this manuscript we also show that both intracellular Zn and
efferocytic capacities of macrophages were decreased in ZIP12/2
mice. It was necessary to use peritoneal macrophages for this, as
there were limitations on the number of alveolar macrophages that
we could isolate. Pregnant ZIP12/2 mice on a low Zn diet were
reported to have increased abnormalities in their embryos
compared to those of ZIP1+/+ mice on the same diet, but no
difference was observed when the null and wildtype mice were on
Zn replete diets [29]. The authors proposed that ZIP1, and the
related transporter ZIP3, modify the effects of Zn deficiency and,
therefore, mutations in these genes might impact a wide array of
disease processes that are exacerbated by Zn deficiency, including
chronic lung inflammatory diseases.
The studies described here begin to address the basic science
questions underlying the role of Zn in AM, including the first
characterization of the subcellular distribution of Zn and Zn
transporters in these cells as well as the role that altered Zn
metabolism plays in efferocytosis. We have identified candidate
ZIP and ZnT type Zn transporters which may function to
maintain cytosolic Zn in Zn deficiency. We have also identified
two Zn transporters ZIP1 and ZIP2 which are candidate plasma
membrane influx Zn transporters for lung macrophages. ZIP1 was
unresponsive to a zinc deficiency signal but was important for
normal efferocytosis function. ZIP2 may play a special role in
maintaining macrophage Zn in the presence of low extracellular
Zn concentrations and this might be important in lung inflam-
mation and injury. Its role, if any, in efferocytosis needs further
investigation. Future studies demonstrating that addition of Zn to
either monocytes or macrophages increases efferocytosis, and
assessing Zn transporter mRNA in human AM will be of
importance for better understanding the role of Zn in macrophage
dysfunction in COPD. Elucidation of the mechanisms leading to
defective efferocytosis in lung injury and disease will provide a
Figure 4. Effect of ZIP1 XO on cytosolic Zn and efferocytosis.
Peritoneal macrophages were harvested from WT mice (n = 25) and
Zip1 KO mice (n = 14). A: Macrophages were stained with FluoZin-3 and
the resulting fluorescence was measured by flow cytometry. Positive
fluorescence was determined by gating relative to an unstained control.
Error bars represent the SEM. B: Macrophages were assayed for
efferocytosis. Results are expressed as a percentage of macrophages
ingesting apoptotic cells. Error bars represent the SEM. * p: ,0.05, ** p:
,0.005.
doi:10.1371/journal.pone.0110056.g004
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foundation for our long term goals of better clinical management
of COPD.
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